A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitus. Lee MK, Kim SG, Watkins E, Moon MK, et al. J Diabetes Complications 2020 Feb 2:107555. doi: 10.1016/j.jdiacomp.2020.107555.

Read + Share

Amedeo Smart

Independent Medical Education

Lee MK, Kim SG, Watkins E, Moon MK, et al. A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitus. J Diabetes Complications 2020 Feb 2:107555. doi: 10.1016/j.jdiacomp.2020.107555.
PMID: 32019723